Buscar resultados de ensayos clínicos
All - 123,355 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: SOM230 Ectopic ACTH-producing Tumors Condición: Ectopic ACTH Syndrome Fecha: 2016-04-26 Intervenciones: Drug: Pasireotide Other Name: SOM230 |
Terminated |
Nombre del estudio: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin Condición:
Intervenciones: Drug: pasireotide LAR Investigational drug pasireotide LAR was supplied in vials with 20 mg or 40 mg pow |
Recruiting |
Nombre del estudio: Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome Condición:
Intervenciones: Drug: Osilodrostat Osilodrostat will be prescribed by the investigator. Osirodrostat 1 mg, 5 mg, 10 mg, |
Recruiting |
Nombre del estudio: Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome Condición: Cushing Syndrome Fecha: 2013-12-21 Intervenciones:
|
Terminated |
Nombre del estudio: Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion Condición: Cushing's Syndrome Fecha: 2007-01-12 Intervenciones: Drug: Mifepristone Singe dose |
Completed |
Nombre del estudio: Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome Condición:
Fecha: 2011-06-07 Intervenciones: Drug: Mifepristone mifepristone at doses from 300mg/day up to 1200mg/day |
Completed |
Nombre del estudio: An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome Condición: Cushing's Syndrome Fecha: 2009-07-09 Intervenciones: Drug: mifepristone Mifepristone 300 mg to 1200 mg once daily |
Terminated |
Nombre del estudio: A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia Condición: Cushing's Syndrome Fecha: 2008-11-20 Intervenciones: Drug: Cushing's syndrome confirmation Other Name: Provide access to standard test procedures. |
Completed |
Nombre del estudio: A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome Condición: Cushing's Syndrome Fecha: 2007-12-05 Intervenciones: Drug: mifepristone Patients take mifepristone by mouth once a day. The dose is increased during schedule |
Recruiting |
Nombre del estudio: Treatment of Cushing's Disease With R-roscovitine Condición: Cushings Disease Fecha: 2014-05-21 Intervenciones: Drug: R-roscovitine See Arm Description Other Names: |